Intravenous extension of lung carcinoma to the left atrium: Demonstration by positron emission tomography with CT correlation

British Journal of Radiology

Volumn 73, Issue 866, 2000, Pages 206-208

  Pitman, A G ^a   Solomon, B ^a   Padmanabhan, R ^a   Mckenzie, A F ^a   Hicks, R J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HEART LEFT ATRIUM; HUMAN; LUNG CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR PROMOTION;

EID: 0034031932     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.866.10884736     Document Type: Article

References (12)

1. Misawa Y, Take A, Yamamoto N, Fukushima K, Hasegawa T, Shimizu H. Systemic tumour emboli from primary bronchogenic carcinoma. Kyobu Geka 1989;42:108-14 (In Japanese).
2. Zhou QH. Pneumonectomy combined with partial resection of left atrium in the treatment of stage IIIb bronchogenic carcinoma. Chung Hua Chung Liu Tsa Chih 1993;15:388-90 (In Chinese).
3. Choe DH, Lee JH, Lee BH, Kim KH, Chin SY, Zo JI, et al. Obliteration of the pulmonary vein in lung cancer: significance in assessing local extent with CT. J Comput Assist Tomogr 1998;22:587-91.
4. Chen MY, Chiles C, Choplin RH, Aquino SL. Bronchogenic carcinoma: a survey of CT protocols for staging disease. Acad Radiol 1997;4:687-92.
5. Cascade PN, Gross BH, Kazerooni EA, Quint LE, Francis IR, Strowderman M, et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT. AJR 1998;170: 927-31.
6. Patz JR EF, Erasmus JJ, McAdams HP, Connolly JE, Marom EM, Goodman PC, et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology 1999;212:56-60.
7. De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W, et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997; 12:706-12.
8. Aristizabal JF, Young KR, Nath H. Can chest CT decrease the use of preoperative bronchoscopy in the evaluation of suspected bronchogenic carcinoma? Chest 1998;113:1244-9.
9. Coleman RE. PET in lung cancer. J Nucl Med 1999;40:814-20.
10. Gambhir SS, Hoh CK, Phelps ME, Mador I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung carcinoma. J Nucl Med 1996;37:1428-36.
11. Scott WJ, Shepherd J, Gambhir SS. Cost effectiveness of FDG PET for staging non small cell lung cancer: a decision analysis. Ann Thorac Surg 1998; 66:1876-83.
12. Plutchok JJ, Boxt LM, Weinberger J, Fawwaz R, Sherman WH, Van Heertum RL. Differentiation of cardiac tumour from thrombus by combined MRI and F-18 FDG PET imaging. Clin Nucl Med 1998; 23:324-5.